- Home
- TTRX
TTRX
Turn Therapeutics Inc. Common Stock
as 10-22-2025 3:55pm EST
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 257.8M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 2.1M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.18 - $26.50 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Turn Therapeutics Inc. Common Stock News
TTRX Breaking Stock News: Dive into TTRX Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones
GlobeNewswire
3 days ago
Turn Therapeutics Launches Webinar Series for Ongoing Shareholder Engagement, First Session October 22, 2025
GlobeNewswire
8 days ago
Turn Therapeutics Appoints Dr. Kent Kester to Board of Directors
GlobeNewswire
9 days ago
Turn Therapeutics Appoints Arthur Golden to Board of Directors
Compare TTRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TTRX Turn Therapeutics Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.